(2-(4-(methyl-d3)piperazin-1-yl-2,2,3,3,5,5,6,6-d8)pyrimidin-5-yl)boronic acid

95%

  • Product Code: 56316
  CAS:    2241877-07-4
Molecular Weight: 233.119779558 g./mol Molecular Formula: C₉H₄BD₁₁N₄O₂
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: -20℃, sealed and dry
Product Description: Used primarily in pharmaceutical research and development, this compound serves as a key intermediate in the synthesis of deuterated drugs. Its boronic acid group facilitates Suzuki-Miyaura cross-coupling reactions, enabling the creation of complex molecules with enhanced stability and pharmacokinetic properties. The deuterated methyl and piperazine groups improve metabolic resistance, making it valuable in the design of deuterated analogs for therapeutic agents, particularly in oncology and neurology. Its application extends to isotope labeling studies, aiding in the investigation of drug metabolism and distribution.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.005 10-20 days ฿86,080.00
+
-
0.025 10-20 days ฿223,800.00
+
-
(2-(4-(methyl-d3)piperazin-1-yl-2,2,3,3,5,5,6,6-d8)pyrimidin-5-yl)boronic acid
Used primarily in pharmaceutical research and development, this compound serves as a key intermediate in the synthesis of deuterated drugs. Its boronic acid group facilitates Suzuki-Miyaura cross-coupling reactions, enabling the creation of complex molecules with enhanced stability and pharmacokinetic properties. The deuterated methyl and piperazine groups improve metabolic resistance, making it valuable in the design of deuterated analogs for therapeutic agents, particularly in oncology and neurology. Its application extends to isotope labeling studies, aiding in the investigation of drug metabolism and distribution.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: ฿0.00
฿0.00 Total :